BIOMAT Database Logo BIOMAT Database Logo

B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells. 1987

F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota, Minneapolis.

The purpose of this study was to analyze the expression of B cell growth factor (BCGF) receptors and to elucidate the biologic effects of biochemically purified natural BCGF at the B cell precursor stage of human B lineage lymphoid differentiation. The specific binding of radioiodinated high-mol-wt BCGF (125I-HMW-BCGF) and low-molecular-wt BCGF (125I-LMW-BCGF) to fresh marrow blasts from B cell precursor acute lymphoblastic leukemia (ALL) patients was initially investigated. The estimated number of radioiodinated BCGF molecules bound per blast ranged from undetectable to 24.3 X 10(3) for HMW-BCGF, and from 11.5 X 10(3) to 457.8 X 10(3) for LMW-BCGF. In 3H-TdR incorporation assays, 75% of cases showed a significant response to LMW-BCGF with a median stimulation index of 9.3. By comparison, only 33% of cases showed a significant response to HMW-BCGF with a median stimulation index of 2.4. Subsequently, B cell precursor colony assays were performed to assess and compare the biologic effects of BCGF on leukemic B lineage lymphoid progenitor cells. Among 28 cases studied, 57% responded to both HMW-BCGF and LMW-BCGF, 21% responded only to LMW-BCGF, and the remaining cases showed no proliferative response to either growth factor. The response patterns of virtually pure populations of FACS-sorted leukemic B cell precursors were essentially identical to the proliferative responses of unsorted leukemic B-cell precursors. Synergistic effects between HMW-BCGF and LMW-BCGF were observed in 80% of the cases that responded to both. The numbers of cell-bound radioiodinated BCGF molecules, the stimulation indices, as well as the number of B cell precursor colonies in BCGF-stimulated cultures showed a marked interpatient variation. Patients with structural chromosomal abnormalities (SCAs) involving 12p11-13 or patients with a Philadelphia chromosome showed a greater HMW-BCGF response at the level of leukemic progenitor cells than did other patients (P = .02). The LMW-BCGF response was significantly greater for patients with SCA than for patients without SCA (P = .04). The response of leukemic progenitor cells to HMW-BCGF or LMW-BCGF did not correlate with sex, age, disease status, FAB morphology, WBC at diagnosis, or immunophenotype. To our knowledge, this study represents the first detailed analyses of BCGF receptor expression and BCGF effects in B cell precursor ALL. The data presented provide direct evidence for the expression of functional receptors for both HMW-BCGF and LMW-BCGF in B cell precursor ALL.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011975 Receptors, Mitogen Glycoprotein molecules on the surface of B- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes. Lectin Receptors,Mitogen Receptors,Receptors, Lectin,Mitogen Receptor,Receptor, Mitogen
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Expression of Tac antigen on human immature B-cell lineage leukemic cells.
January 1986, Leukemia research,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Heterogeneity of cultured leukemic lymphoid progenitor cells from B cell precursor acute lymphoblastic leukemia (ALL) patients.
September 1987, The Journal of clinical investigation,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
TGF-beta and its receptor complex in leukemic B-cell precursors.
November 1998, Experimental hematology,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells.
October 1984, Journal of immunology (Baltimore, Md. : 1950),
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Fas receptor expression on B-lineage cells.
November 1995, European journal of immunology,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
March 1997, Leukemia,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors.
February 2017, Cell reports,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
August 2006, European journal of haematology,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression.
March 2004, Leukemia,
F M Uckun, and A S Fauci, and N A Heerema, and C W Song, and S R Mehta, and K Gajl-Peczalska, and M Chandan, and J L Ambrus
Transforming growth factor-beta increases the expression of vascular smooth muscle cell markers in human multi-lineage progenitor cells.
February 2011, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!